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The aim of the study was to establish the characteristics of presentation of 94 patients with Kinelfelter’s syndrome (KS) referred
to the endocrinologist at diﬀerent ages. The diagnosis of KS was more frequent in the age group between 11 and 20 years
(46.8%). Most of the patients (83.7%) showed the classic 47,XXY karyotype and 7.1% showed a 47,XXY/46,XY mosaicism. Half
of the patients younger than 18 years presented mild neurodevelopmental disorders. The most frequent clinical ﬁndings were
cryptorchidism in prepubertal patients, and small testes, cryptorchidism, and gynecomastia in pubertal patients. FSH, LH, AMH,
and inhibin B levels were normal in prepubertal patients and became abnormal from midpuberty. Most adults were referred for
small testes, infertility, and gynecomastia; 43.6% had sexual dysfunction. Testosterone levels were low in 45%. Mean stature was
abovethe50thpercentile,and62.5%hadBMI ≥ 25.0kg/m 2.Inconclusion,thediagnosisofKlinefeltersyndromeseemstobemade
earlier nowadays probably because pediatricians are more aware that boys and adolescents with neuro-developmental disorders
and cryptorchidism are at increased risk. The increasing use of prenatal diagnosis has also decreased the mean age at diagnosis and
allowed to get insight into the evolution of previously undiagnosed cases, which probably represent the mildest forms. In adults
average height and weight are slightly higher than those in the normal population. Bone mineral density is mildly aﬀected, more
at the spine than at the femoral neck level, in less than half of cases.
1.Introduction
The original clinical presentation of Klinefelter’s syndrome
was described by Klinefelter’s, Reifenstein, and Albright in
1942, who reported 9 adult males with gynecomastia, small
and ﬁrm testes, azoospermia, and elevation of serum FSH
with functional Leydig, cells [1]. In 1959, using cytogenetics,
Jacobs and Strong described the existence of an extra X
chromosome, that is, 47,XXY karyotype, in a male with
Klinefelter’s syndrome [2]. This classical karyotype is present
in approximately 90% of the cases. Patients with mosaicisms
or with pure cell lineages carrying one or more extra
X chromosomes and at least one Y chromosome (e.g.,
47,XXY/46,XY, 47,XXY/45,X/46,XY, 48,XXXY, 49,XXXXY,
48,XXYY, etc.) are also considered as Klinefelter’s syndrome
variants, although the clinical presentation may be quite
diﬀerent in some cases [3].
Because chromosomal and gonadal features are atypical
in Klinefelter’s syndrome, the condition has been included as
a disorder of sex development by the International Consen-
sus Conference organized by the Lawson Wilkins Pediatric2 International Journal of Endocrinology
Endocrine Society and the European Society for Paediatric
Endocrinology in 2006 [4, 5]. Furthermore, Klinefelter’s
syndrome is characterized by a genetic, whole gonadal
dysfunction[6],aﬀectinggermcellsfromearlyfetallife[7,8]
and Sertoli’s and Leydig’s cells from mid-puberty [9].
From an endocrinological standpoint, patient’s com-
plaints may vary, according to gonadal dysfunction, from
signs of sex hormone deﬁciency in young adults to infertility
in a male without other signs of hypogonadism. Before
puberty, the condition is usually underdiagnosed due to the
fact that childhood is a period characterized by physiolog-
ically low androgen levels and no sperm production [3].
Cryptorchidism and mild developmental disorders may be
the alerting signs.
The main objective of this study was to establish the
frequency and clinical characteristics of the diﬀerent forms
of presentation of Klinefelter’s syndrome at diﬀerent ages in
a large cohort of patients.
2. Patientsand Methods
We performed a retrospective chart analysis that included all
patientswithaconﬁrmeddiagnosisofKlinefelter’ssyndrome
of 5 diﬀerent centers in Buenos Aires, Argentina, from
1982 to 2008. The deﬁnition of Klinefelter’s syndrome, as
inclusion criterion for this study, required the availability
of a karyotype consisting of an X-chromosome polysomy
and at least one Y chromosome, either as a single lineage or
as a mosaicism. The karyotype was analyzed in at least 30
metaphases.
The study was approved by the review boards of the
participating institutions.
The main outcome measures were age at diagnosis, fre-
quency of history or existence of cryptorchidism, gyneco-
mastia, neuro-developmental disorders and signs of hypogo-
nadism and serum hormone levels (FSH, LH, testosterone,
AMH, inhibin B, estradiol, prolactin, TSH, and thyroid
hormones), lipid and carbohydrate proﬁles, sperm analysis,
and bone mineral density measurement at referral. Results
were expressed as the prevalence (frequency of presentation
at referral) or as the mean ± standard deviation or median
and range, as applicable. Where necessary, quantitative vari-
ables were transformed into qualitative ones. For instance,
hormone levels were classiﬁed as normal, elevated, or low
according to the reference ranges for age. Data were analyzed
usingInstatStatisticalSoftware(GraphPadSoftware,Version
3.01). Pearson’s correlation coeﬃcients and two-sample t-
test for continuous variables were used. P values below 0.05
were considered to indicate statistical signiﬁcance.
3. Results
Records from 98 patients with Klinefelter’s syndrome were
analyzed:44ofthemwereunder18yroldatreferral(18were
u n d e r1 0yro l da n d2 6w e r eb e t w e e n1 0a n d1 7 . 9yro l d ) ,a n d
54 were aged 18yr or older. The most prevalent age range
at diagnosis was 11–20yr (Figure 1). A prenatal diagnosis
was made in 4 cases. Karyotype was 47,XXY in 83.7% and
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Figure 1: Age at diagnosis of the 94 patients of the present study.
Table 1: Karyotypes found in the 98 patients of this study.
Karyotype n %
Pure lineage 86 87.76
47,XXY 82 83.67
48,XXXY 1 1.02
48,XXYY 3 3.06
Mosaicisms 12 12.24
47,XXY/46,XY 7 7.14
47,XXY/48,XXYY 2 2.04
47,XXY[4]/48,XXXY[2]/46,XY[44] 1 1.02
49,XXXXY[44]/48,XXXY[6] 1 1.02
47,XXY[36]/48,XXXY[1]/46,XX[1]/46,XY[2] 1 1.02
Table 2: Prevalence of clinical signs in pediatric and adolescent
patients with Klinefelter’s syndrome.
Prepubertal
(n = 18)
Pubertal
(n = 26)
Neuro-developmental disorders 8 (44.4%) 14 (53.8%)
Small testes 3 (16.7%) 20 (76.9%)
Cryptorchidism 10 (55.5%) 6 (23.0%)
Gynecomastia 0 (0%) 11 (42.3%)
Small penis 3 (16.7%) 3 (11.5%)
Prenatal diagnosis 4 (22.2%) 0 (0%)
Pie bot 1 (5.5%) 0 (0%)
Varicocele 3 (11.5%) 3 (11.5%)
Dysmorphisms 1 (3.8%) 1 (3.8%)
47,XXY/46,XY in 7.1% of the 98 patients; the other variants
were homogeneously infrequent (Table 1).
3.1. Pediatric and Adolescent Patients with Klinefelter’s Syn-
drome. The age group below 18yr old was subclassiﬁed
according to their pubertal status in prepubertal (median
age 5.07yr, range 0.75–9.28yr) and pubertal (median age
14.3yr, range 10.1–17.7yr). In the prepubertal patients,
cryptorchidism and neuro-developmental disorders, includ-
ing behavior and/or learning diﬃculties, were the most
prevalent ﬁndings (Table 2). In pubertal patients, the most
frequent ﬁndings were small testes, neuro-developmental
disorders, and gynecomastia.International Journal of Endocrinology 3
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Figure 2: Serum hormone levels in pediatric and adolescent patients with Klinefelter’s syndrome.
Table 3: Prevalence of main complaints and clinical signs and
symptoms in adult patients with Klinefelter’s syndrome.
Main complaints %
Infertility 34.8
Small testes 34.8
Gynecomastia 10.9
Erectile dysfunction 6.5
Hypergonadotrophic hypogonadism 4.3
Eunuchoid proportions 2.2
Decreased libido 2.2
Signs and symptoms %
Small testes 100
Infertility 100
Eunuchoid proportions 35.2
Gynecomastia 31.3
Erectile dysfunction 29.3
Reduced libido 27.5
Varicocele 23.3
Neurodevelopmental disorders 22.0
Small penis 0
Anthropometric evaluation was performed in boys and
adolescents. The mean ± SD height standard deviation
score (SDS) was 0.3 ± 1.8( m e d i a n0 . 7 ,r a n g e−4.1 to 3.6)
in prepubertal patients, and 1.1 ± 1.1 (median 1.1, range
−1.4 to 2.9) in pubertal patients. SDS 0 represents the
50th percentile for the Argentine population, −2 is the
3rd percentile, and +2 is the 97th percentile. Our data
indicate that pubertal patients with Klinefelter’s syndrome
were signiﬁcantly higher (P<0.0001). While height SDS
above +2 was found in one prepubertal patient, it was above
+2 in 5 pubertal patients. There was a signiﬁcant correlation
between height SDS and age (n = 40, r = 0.304, P<0.05).
Weight for height was adequate in most patients, except
one prepubertal and 7 pubertal boys, with a body mass
index (BMI) above the 95th percentile for age. Evaluation
of the genitalia showed the existence of reduced penile size
in 16.7% and 11.5% of prepubertal and pubertal patients,
respectively, (Table 2). Testes were bilaterally nonpalpable
in 22.2% of prepubertal patients. In those with palpable
gonads, testicular volume was 1-2mL in all cases except
three (21.4%), who had abnormally small testes (<1mL).
In pubertal patients, testicular volume was below normal in
all patients in the Tanner stages 3–5 (median 3.7mL, range
1–8mL). Bilateral gynecomastia was observed in 11 cases
(42.3%). Varicocele was found in 3 cases (11.5%).
Evaluation of the reproductive axis hormone levels
was available during followup in 13 prepubertal and 28
pubertal patients with Klinefelter’s syndrome (Figure 2).
FSH, LH, testosterone, inhibin B, and AMH levels were
normal in all prepubertal boys. In pubertal patients, FSH
and LH increased above the normal at 12.8yr and 13.8yr,
respectively. A negative correlation was found between age
and FSH (r =− 0.62, P<0.001) and age and LH (r =
−0.59, P<0.001). Serum AMH and inhibin B fell below
normalfrompubertalTannerstage3.Testosteronewasbelow
normal, and hormone replacement therapy was indicated, in
7 of 28 pubertal patients (25%) before the age of 18yr.
3.2.AdultPatientswithKlinefelter’sSyndrome. Infertilityand
small testes were the most prevalent complaints in adult
patients (Table 3). Sexual function inquiry revealed reduced
libido in 27.5% of patients and erectile dysfunction in 29.3%
(Table 3). Information on maximal education level was
available in 26 patients: 42.3% attained tertiary education.
Anthropometric evaluation revealed a median height
above the 50th percentile for the Argentine male population
(mean ± SD = 178.8 ± 9.0cm, median 180cm, range
161–200cm) and a slight overweight (mean ± SD weight
83.6 ± 21.0kg, median 83.5kg, range 53–171; mean ± SD4 International Journal of Endocrinology
Table 4: Serum levels of reproductive axis hormones and carbohydrate and lipid proﬁles in adult patients with Klinefelter’s syndrome.
Mean ± SD % Abnormal Reference levels
FSH (IU/L) 35.4 ±16.2 100 1–8
LH (IU/L) 22.3 ±11.6 83.0 2–12
Total testosterone (ng/mL) 2.74 ±1.65 45.1 2.8–8.8
Estradiol (pg/mL) 26.5 ±13.2 6.3 18–44
Prolactin (ng/mL) 16.5 ±11.3 33.3 5–20
TSH (µU/mL) 2.11 ±0.99 0.0 0.47–4.64
Fasting glucose (mg/dL) 91.5 ±13.1 0.0 70–110
Total cholesterol (mg/dL) 189 ±40 40.0 110–200
LDL (mg/dL) 124 ±36 50.0 <130
HDL (mg/dL) 43 ±7 47.4 >40
Triglycerides (mg/dL) 115 ±77 15.0 50–200
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Figure 3: Serum testosterone levels in adult patients with Klinefel-
ter’s syndrome. Age versus testosterone: r : −0.5, P<0.001.
BMI 26.4 ± 5.5kg/m 2, median 25.9kg/m2, range 17.2–
51.1kg/m2)1 9p a t i e n t s( 4 7 . 5 % )h a daB M Ib e t w e e n2 5a n d
29.9kg/m2, and 6 patients (15%) were overtly obese (BMI >
30kg/m2). Eunuchoid proportions were observed in 35.2%
of patients.
Evaluation of the genitalia showed small testes in all cases
(median 3.5mL, range 1–8mL), varicocele in 23.3%, and
gynecomastia in 31.3% (bilateral in most of the cases).
Laboratory measurements (Table 4) revealed elevated
FSH in 100% of cases and LH in 83%. Half of the patients
with normal LH had subnormal total testosterone levels.
Total testosterone decreased with age (Figure 3), and a
negative correlation (r =− 0.50, P<0.001) was found
between these variables. In the adult group as a whole,
total testosterone was below normal in 45.1% of the cases.
Prolactin was slightly elevated in 33% and estradiol in 6.2%
of the cases. Semen analysis showed azoospermia in 89.3%
of the cases and oligozoospermia in the remaining cases. No
association was found with the karyotype. Total cholesterol
was >200mg/dL in 40%, LDL was >130mg/dL in 50%, and
HDL was <45mg/dL in 47.4% of the cases. Fasting glucose
levels were within the normal range in all patients.
Evaluation of bone mineral density (BMD) by DXA was
performed in 27 adult patients. Results of BMD at lumbar
spinewerenormalin59.3%andshowedosteopeniain33.3%
and osteoporosis in 7.4% of the cases. At the femoral neck
level, BMD was normal in 72% and showed osteopenia in
28% of the cases, with no cases of osteoporosis.
4. Discussion
Klinefelter’s syndrome is the commonest chromosomal ab-
normality in humans, with an estimated prevalence of 1
in 600 live births in males [3]. However, the condition is
usually underdiagnosed, with an estimated 25% of the ex-
pected number of patients being ever diagnosed, and only
a minority being diagnosed in childhood [10]. This may be
due to the fact that Klinefelter’s syndrome was initially a
clinical diagnosis of adult males classically described as tall,
with gynecomastia, small testes, azoospermia, sparse body
hair,narrowshoulders,andbroadhips.ThoseXXYmalesnot
presenting these typical features are probably missed, as are
almost90%ofprepubertalpatientsinwhomthediagnosisof
hypogonadism is usually delayed until puberty [6]. Here we
report the clinical and biochemical ﬁndings in a large cohort
of Klinefelter’s patients from pediatric age through adult-
hood. This is the largest series of patients with Klinefelter’s
syndrome in the literature. We are aware that a selection bias
exists in our series, since all patients had been referred to a
pediatric or adult endocrinologist. Therefore, the prevalence
of clinical and biochemical ﬁndings in children, adolescents,
and adults with Klinefelter’s syndrome we report herein is
applicable to those expected in an endocrinology setting.
The most prevalent age at diagnosis in our series was
during adolescence, with more than half of our patients
being diagnosed before adult age. This may reﬂect the fact
that pediatricians and pediatric neurologists are increasingly
aware of the increased prevalence of XXY karyotype in
boys with mild neuro-developmental disorders, resulting
in a rise in the diagnosis and early referral to the pedi-
atric endocrinologist. Another reason may be the fact that
cryptorchidism, a frequent cause of referral to the pediatric
endocrinologist, is more frequent in patients with Kline-
felter’s syndrome [11–14]. In fact, the frequency of cryp-
torchidism was high in our series, mainly in the pediatricInternational Journal of Endocrinology 5
population. The almost tenfold higher prevalence of Kline-
felter’s syndrome in cryptorchid boys [11, 12] supports the
indication of a karyotype analysis.
In coincidence with the initial characterization of long-
term outcomes [15] and, more recently, of longitudinal
growth in patients with Klinefelter’s syndrome [16], our
patientswereslightlytallerthanthegeneralmalepopulation.
In boys and adolescents, we observed a positive correlation
between age and stature. Eunuchoid proportions cannot be
ascribed to hypoandrogenism since the increased height is
present before pubertal onset, but rather to the existence
of an extra copy of the SHOX gene, mapping to X and Y
chromosomes and involved in linear growth [17]. It should
be noted, however, that the height of 19% of our adult
patients fell below the 50th percentile for the Argentine
population, indicating that tall stature is not a prerequisite
for the diagnosis of Klinefelter’s syndrome.
A dissociated gonadal dysfunction with lack of sperm in
semen and reduced testis volume, reﬂecting a severe disorder
of the seminiferous tubules, with normal/low testosterone
levels, indicating a mild dysfunction of the interstitial com-
partment, was described in the initial report by Klinefelter’s
and colleagues [1]. Our results, together with other recent
reports [7–9, 18, 19], further indicate that the establishment
of the dysfunction of the seminiferous tubule components
is also dissociated. In fact, germ cells are already aﬀected
in early postnatal life while Sertoli’s cells secrete normal
levels of AMH and inhibin B until mid-puberty. Similarly,
Leydig’s cells seem to produce androgens normally until
mid-puberty; thereafter, although androgen levels might be
within the normal range in a proportion of patients with
Klinefelter’s syndrome, there is an increase in LH, indicating
a suboptimal Leydig cell functional capacity. Our results
show that FSH levels are increased approximately one year
before LH levels during puberty in patients with Klinefelter’s
syndrome, which suggests that Sertoli’s cell function is
aﬀected not only more severely than that of Leydig’s cells
but also earlier. The age for testosterone replacement in these
patients is controversial, yet clear clinical and biochemical
signs of hypoandrogenism are an undisputed indication for
the initiation of androgen therapy [20]. In our series, 7
patients required testosterone replacement before the age
of 18yr. Decreased Leydig’s cell function has also been
detected by measuring INSL3 [21, 22] and conﬁrmed by
histologicalstudiesshowingincreasedinterstitialﬁbrosisand
decreased androgen receptor expression with age [7, 23].
Nonetheless, the indication for androgen therapy should
not be unnecessarily anticipated, since the likelihood of
obtainingspermseemstodecreaseoncetreatmentisinitiated
[24].
Lipid metabolism was abnormal in a variable proportion
of our patients, as revealed mainly by the measurement
of total cholesterol and its fractions, in coincidence with a
recent report [25]. The latter study shows that the disorder
in the lipid metabolism could not be modiﬁed by androgen
therapy. Bone mineral density was mildly decreased in our
patients, in line with a recent report in Korean males, which
showed no signiﬁcant correlation with androgen deﬁciency
[26].
In conclusion, the diagnosis of Klinefelter’s syndrome
was more frequent between 11 and 20yr of age in our series,
probably due to the fact that in the last years pediatricians
have become more aware of the likelihood of the diagnosis
inboysandadolescentswithneuro-developmentaldisorders,
cryptorchidism, and small testes. The increasing use of pre-
natal diagnosis has also decreased the mean age at diagnosis
and allowed to get insight into the evolution of previously
undiagnosed cases, which probably represent the mildest
forms. The function of the hypothalamic-pituitary-gonadal
axis is preserved during infancy and childhood, with a
progressive decline of the seminiferous tubule compartment
from mid-puberty. The Leydig cell compartment shows a
mild dysfunction compensated by an increase in LH during
late puberty and early adulthood. As previously described,
hypoandrogenism occurs in an increasing proportion of
patients with age. Small testes, infertility, gynecomastia.
decreased libido, and sexual or ejaculatory dysfunction were
associated complaints. In adults average height and weight
are slightly higher than in the normal population. Bone
mineral density is mildly aﬀected, more at the spine than at
the femoral neck level, in less than half of cases.
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